Nowadays, China's vaccines have been recognized by all countries in the world, and 15 countries have signed contracts with China to purchase vaccines. As a world power, Germany is also very excited about China's vaccines. It can also be seen from this that China has been favored by developed countries in vaccine research and development, and it also shows that China has made remarkable achievements in medical treatment in recent years.
Chinese vaccines have also become increasingly important. Among them, the U.S. media has recently come back and acknowledge the effectiveness of Chinese vaccines.
The New York Times published an article entitled "It's Time to Trust the Vaccines of China and Russia" on the 5th local time. The article pointed out that Chinese and Russian vaccines have been scientifically proven to be safe and effective and are recognized by their peers. When the global vaccine distribution is unfair and there is a shortage of vaccines in Europe, the article calls on Western countries to trust the new crown vaccine developed by China and Russia to make up for the vaccination gap in various countries.
The report also pointed out that in the recent period, the UAE, Bahrain, Egypt, Jordan, Iraq, Serbia, Morocco, Hungary and Pakistan have approved the Chinese National Medicine vaccine; as of mid-January 2021, 1.8 million people in the UAE have been vaccinated with the Chinese vaccine. In addition, EU countries are facing severe vaccine shortages and delivery delays. France, Spain and Germany are now talking about the possibility of ordering vaccines from China and Russia. In the face of difficulties, they clamored for “prejudice” against non-Western vaccines.
For the various achievements made by China's vaccines in the world, the World Health Organization has spoken quickly and praised them. On the 4th local time, the WHO Regional Office for Africa held an online press conference in Brazzaville, capital of Congo (Brazzaville), to introduce the first phase of vaccination arrangements for the "New Coronary Pneumonia Vaccine Implementation Plan" in Africa. Richard Michgo, the head of the WHO African Region Immunization and Vaccine Development Project, said at the meeting that China's provision of vaccines to the "New Coronary Pneumonia Vaccine Implementation Plan" reflects the spirit of global solidarity in fighting the epidemic. In addition, Mary Angela Simao, Assistant Director-General of WHO, also said that the evaluation process of China's new crown vaccine is at a very late stage.
After the research and development of the new crown vaccine is completed and put into use in China, it will serve as a global public product and make China's contribution to the realization of the vaccine's accessibility and affordability in developing countries.
The Chinese vaccine, which has received a lot of praise in the world, has also attracted the attention of some Western leaders. The Serbian news website "B92" released a report on February 3, 2021, that German Chancellor Merkel admitted in an interview with German media the day before that with the Chinese vaccine, countries like Serbia are "vaccinating faster than other European countries.
After Merkel, French President Macron also made an important statement to China in recent days. According to Bloomberg News, on February 4, local time, French President Macron stated in a speech at an online seminar hosted by the Atlantic Council of the United States that China’s efficiency in producing and exporting vaccines "makes us a little ashamed."
So far, more than 40 countries have put forward the need to import Chinese vaccines. Judging from the number of orders, China Vaccine has at least won contracts for over 500 million doses of vaccines in 16 countries and regions.
European Union countries are facing severe vaccine shortages and delivery delays. France, Spain and Germany are now talking about the possibility of purchasing Chinese vaccines. Austrian Chancellor Kurz also tweeted on February 4: “There should be no geopolitical taboo in accepting vaccines. Obviously, the European Medicines Agency (EMA) should test the applicability of Chinese vaccines.”